Dame Margaret's words in a presentation reported back in 2013/14 when I first bought into Neuren's story still resonate with me; ... to the effect that ... 'the accountants made us proceed with NNZ2566(now Trofinitide) because it was the best prospect in our stable for earliest commercialisation, but in my mind the jewel in our crown is NNZ2591.'
I've held the faith since then. Not a huge stake, and have always thought it was a good chance for $15-$20+ (75c-$1 pre-consolidation). Never joined the $5 club.
I'm heavier into PTX and IMU which are likely to be bigger on account of their multiple molecules and truly groundbreaking therapies, but still have a very soft spot for NEU.
Not long now, folks.
Updated MST report - target of $3.68 a share, page-112
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 249 | $20.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 790 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |